FR22C1061I1 - Oligosaccharides comprenant un groupe aminooxy et des conjugues de celui-ci - Google Patents

Oligosaccharides comprenant un groupe aminooxy et des conjugues de celui-ci

Info

Publication number
FR22C1061I1
FR22C1061I1 FR22C1061C FR22C1061C FR22C1061I1 FR 22C1061 I1 FR22C1061 I1 FR 22C1061I1 FR 22C1061 C FR22C1061 C FR 22C1061C FR 22C1061 C FR22C1061 C FR 22C1061C FR 22C1061 I1 FR22C1061 I1 FR 22C1061I1
Authority
FR
France
Prior art keywords
oligosaccharides
conjugates
aminooxy group
aminooxy
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR22C1061C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of FR22C1061I1 publication Critical patent/FR22C1061I1/fr
Application granted granted Critical
Publication of FR22C1061I2 publication Critical patent/FR22C1061I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/04—Phosphoric diester hydrolases (3.1.4)
    • C12Y301/04012—Sphingomyelin phosphodiesterase (3.1.4.12)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0102—Alpha-glucosidase (3.2.1.20)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01022—Alpha-galactosidase (3.2.1.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01076—L-Iduronidase (3.2.1.76)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FR22C1061C 2007-01-18 2022-12-15 Oligosaccharides comprenant un groupe aminooxy et des conjugues de celui-ci Active FR22C1061I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88547107P 2007-01-18 2007-01-18
PCT/US2008/051429 WO2008089403A2 (fr) 2007-01-18 2008-01-18 Oligosaccharides comprenant un groupe aminooxy et des conjugués de celui-ci

Publications (2)

Publication Number Publication Date
FR22C1061I1 true FR22C1061I1 (fr) 2023-02-03
FR22C1061I2 FR22C1061I2 (fr) 2023-11-17

Family

ID=39473250

Family Applications (1)

Application Number Title Priority Date Filing Date
FR22C1061C Active FR22C1061I2 (fr) 2007-01-18 2022-12-15 Oligosaccharides comprenant un groupe aminooxy et des conjugues de celui-ci

Country Status (19)

Country Link
US (5) US8759501B2 (fr)
EP (5) EP2457919B1 (fr)
JP (6) JP5999867B2 (fr)
CN (2) CN102978185B (fr)
CA (1) CA2675968C (fr)
CY (2) CY1119954T1 (fr)
DK (3) DK2457920T3 (fr)
ES (3) ES2417146T3 (fr)
FR (1) FR22C1061I2 (fr)
HR (3) HRP20130744T1 (fr)
HU (3) HUE045046T2 (fr)
IL (3) IL243117B2 (fr)
LT (2) LT2457919T (fr)
NL (1) NL301210I2 (fr)
NO (2) NO2457920T3 (fr)
PL (3) PL2457920T3 (fr)
PT (3) PT2457920T (fr)
SI (2) SI2457919T1 (fr)
WO (1) WO2008089403A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7723296B2 (en) 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
WO2008013735A2 (fr) * 2006-07-21 2008-01-31 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Procédés de conjugaison d'oligosaccharides ou de polysaccharides à des supports protéiques par des liaisons oxime au moyen d'acides 3-désoxy-d-manno-octulsoniques
DK2457920T3 (en) 2007-01-18 2018-01-22 Genzyme Corp Oligosaccharides comprising an amino oxy group and conjugates thereof
CA2696699A1 (fr) 2007-08-20 2009-02-26 Protalix Ltd. Conjugues de proteines contenant un saccharide et leurs utilisations
US8835614B2 (en) * 2008-12-16 2014-09-16 Genzyme Corporation Oligosaccharide-protein conjugates
WO2011000958A1 (fr) 2009-07-03 2011-01-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Composés ciblant le récepteur du mannose 6-phosphate cation indépendant
SG10201401194VA (en) * 2009-07-27 2014-07-30 Lipoxen Technologies Ltd Glycopolysialylation of non-blood coagulation proteins
AU2010277438B2 (en) 2009-07-27 2015-08-20 Baxalta GmbH Glycopolysialylation of non-blood coagulation proteins
US9194011B2 (en) 2009-11-17 2015-11-24 Protalix Ltd. Stabilized alpha-galactosidase and uses thereof
WO2011163568A1 (fr) * 2010-06-24 2011-12-29 University Of Kansas Conjugués comportant une liaison n-oxime et procédés associés
WO2012082635A1 (fr) * 2010-12-13 2012-06-21 Ancora Pharmaceuticals, Inc. Streptocoque du groupe a à base d'oligosaccharides synthétiques
JP5913372B2 (ja) 2011-01-20 2016-04-27 プロタリクス リミテッド 植物および植物細胞におけるα−ガラクトシダーゼの発現のための核酸発現構築物
WO2014130723A1 (fr) 2013-02-20 2014-08-28 Valerion Therapeutics, Llc Méthodes et compositions pour le traitement de la maladie de pompe
GB201508025D0 (en) 2015-05-11 2015-06-24 Ucl Business Plc Fabry disease gene therapy
TWI821227B (zh) 2017-12-22 2023-11-11 美商健臻公司 胺甲喋呤誘發的免疫耐受性之生物標記
EP3877424A2 (fr) * 2018-11-08 2021-09-15 Kaleido Biosciences, Inc. Compositions oligosaccharidiques et leurs procédés d'utilisation
JP2023513168A (ja) 2020-02-07 2023-03-30 ノバルティス アーゲー 標的化された血漿タンパク質分解
EP4100120A1 (fr) 2020-02-08 2022-12-14 Genzyme Corporation Compositions et méthodes de traitement de la maladie de pompe
WO2021257409A1 (fr) 2020-06-14 2021-12-23 Genzyme Corporation Compositions et méthodes de traitement de la maladie de pompe tardive

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701521A (en) * 1978-07-17 1987-10-20 The Trustees Of Boston University Method of effecting cellular uptake of molecules
DE2940845B1 (de) 1979-10-09 1980-06-26 Ford Werke Ag Kreiselpumpendichtung,insbesondere fuer Kuehlwasserpumpen in Kraftfahrzeugen
US4671958A (en) * 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
US5066789A (en) * 1988-09-30 1991-11-19 Neorx Corporation Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages
IL93432A (en) 1989-02-24 1994-02-27 Johnson Mathey Inc Hydrazines and hydrazides, their conjugates with macromolecules, and such conjugates labeled with metallic ions
US5206370A (en) * 1989-02-24 1993-04-27 Johnson Matthey, Inc. Certain pyridyl hydrazines and hydrazides useful for protein labeling
US5280113A (en) * 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5212298A (en) * 1989-08-16 1993-05-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5324663A (en) * 1990-02-14 1994-06-28 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
US5583042A (en) * 1990-04-16 1996-12-10 Neose Pharmaceuticals, Inc. Apparatus for the synthesis of saccharide compositions
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
CA2073511A1 (fr) * 1990-11-14 1992-05-29 Matthew R. Callstrom Produits de conjugaison entre un poly(vinylglucide) et des proteines dans le but de stabiliser les proteines
WO1992016212A1 (fr) * 1991-03-13 1992-10-01 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Augmentation de l'efficacite therapeutique d'agents therapeutiques visant des macrophages par regulation positive de la lectine de mannose sur des macrophages
AU1676992A (en) 1991-03-18 1992-10-21 Enzon, Inc. Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers
FR2721612B1 (fr) * 1994-06-23 1996-08-09 Idm Nouveaux dérivés d'oligosides, leur procédé de préparation et leurs applications.
US6132764A (en) * 1994-08-05 2000-10-17 Targesome, Inc. Targeted polymerized liposome diagnostic and treatment agents
US6071890A (en) 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
US6118045A (en) * 1995-08-02 2000-09-12 Pharming B.V. Lysosomal proteins produced in the milk of transgenic animals
AUPO190596A0 (en) * 1996-08-26 1996-09-19 Alchemia Pty Ltd Oligosaccharide synthesis
ATE451124T1 (de) * 1997-01-21 2009-12-15 Sanofi Pasteur Polysaccharid-peptid-konjugate
US5952516A (en) 1997-05-08 1999-09-14 Genzyme Corporation Cationic amphiphiles containing multiplesteroid lipophilic groups
WO2000009153A1 (fr) 1997-10-29 2000-02-24 Genzyme Corporation Compositions et procedes pour traiter les maladies lysosomiales
US6287857B1 (en) 1998-02-09 2001-09-11 Genzyme Corporation Nucleic acid delivery vehicles
US6538117B1 (en) * 1999-08-10 2003-03-25 The Scripps Research Institute Programmable one-pot oligosaccharide synthesis
AU771330B2 (en) * 1998-08-19 2004-03-18 Baxter Healthcare Sa Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide
US6399575B1 (en) * 1998-11-10 2002-06-04 Auburn University Methods and compositions for targeting compounds to the central nervous system
EP1035137A1 (fr) 1999-03-12 2000-09-13 Pasteur Merieux Serums Et Vaccins Procédé d'amination réductrice des polysaccharides
CA2376057A1 (fr) * 1999-06-08 2000-12-14 La Jolla Pharmaceutical Company Molecules a plate-forme de valences comportant des groupes amino-oxy
US6770468B1 (en) * 1999-09-14 2004-08-03 Genzyme Glycobiology Research Institute, Inc. Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
US6642038B1 (en) * 1999-09-14 2003-11-04 Genzyme Glycobiology Research Institute, Inc. GlcNAc phosphotransferase of the lysosomal targeting pathway
JP2003522806A (ja) 2000-02-15 2003-07-29 ジェンザイム、コーポレーション 改良された薬物送達のための生体高分子の修飾
US6749865B2 (en) * 2000-02-15 2004-06-15 Genzyme Corporation Modification of biopolymers for improved drug delivery
US20040067527A1 (en) 2000-07-26 2004-04-08 Sara Lavi Intracellular delivery system for protein phosphatases and other polypeptides
AU2001286539B2 (en) * 2000-08-18 2007-01-04 Massachusetts Institute Of Technology Apparatus and methods for the automated synthesis of oligosaccharides
US6676963B1 (en) * 2000-10-27 2004-01-13 Barnes-Jewish Hospital Ligand-targeted emulsions carrying bioactive agents
US7723296B2 (en) 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
US7001994B2 (en) 2001-01-18 2006-02-21 Genzyme Corporation Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins
ATE384736T1 (de) * 2001-04-30 2008-02-15 Zystor Therapeutics Inc Subzelluläres targeting von therapeutischen proteinen
US7560424B2 (en) * 2001-04-30 2009-07-14 Zystor Therapeutics, Inc. Targeted therapeutic proteins
US7629309B2 (en) * 2002-05-29 2009-12-08 Zystor Therapeutics, Inc. Targeted therapeutic proteins
CA2408387A1 (fr) 2001-05-07 2001-11-29 Lioudmila Tchistiakova Ligand pour ameliorer l'administration d'agents biologiques par voie orale et via le systeme nerveux central
ES2399323T3 (es) * 2001-07-16 2013-03-27 Genzyme Corporation Síntesis de inhibidores de la UDP-glucosa:N-acilesfingosina glucosiltransferasa
US7265084B2 (en) * 2001-10-10 2007-09-04 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
DK1578771T3 (da) 2001-10-10 2013-06-10 Novo Nordisk As Remodellering og glycokonjugering af peptider
WO2003045928A1 (fr) 2001-11-26 2003-06-05 Genzyme Corporation Synthese diastereoselective d'udp-glucose : inhibiteurs de la n-acylsphingosine glucosyltransferase
US6905856B2 (en) * 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
US6800472B2 (en) * 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
JP2006506317A (ja) 2002-01-11 2006-02-23 バイオマリン ファーマシューティカル インコーポレイテッド 治療用リソソーム酵素の送達のための酵素送達系としてのｐ９７の使用
TWI295483B (en) 2002-01-31 2008-04-01 Sumitomo Chemical Co 3-5 group compound semiconductor, process for producing the same, and compound semiconductor element using the same
ATE441706T1 (de) * 2002-02-20 2009-09-15 Gen Hospital Corp Konjugate mit biologisch abbaubarem polymer und verwendung dafür
US6916802B2 (en) 2002-04-29 2005-07-12 Genzyme Corporation Amino ceramide-like compounds and therapeutic methods of use
BR0314106A (pt) 2002-09-11 2005-07-19 Fresenius Kabi De Gmbh Polipeptìdeos hasilados, especialmente eritropoietina hasilada
EP1400533A1 (fr) * 2002-09-11 2004-03-24 Fresenius Kabi Deutschland GmbH Polypeptides hasylés, érythropoiétine hasylée en particulier
WO2005002515A2 (fr) 2003-06-20 2005-01-13 Biomarin Pharmaceutical Inc. Administration de composes therapeutiques au cerveau et a d'autres tissus
US20050026823A1 (en) * 2003-06-20 2005-02-03 Biomarin Pharmaceutical Inc. Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
EP1654004A2 (fr) 2003-08-08 2006-05-10 Novo Nordisk A/S Synthese et utilisation de nouveaux polymeres ramifies structuraux bien definis comme agents de conjugaison de peptides
JP2007501888A (ja) 2003-08-12 2007-02-01 リポクセン テクノロジーズ リミテッド ポリシアル酸誘導体
US7442372B2 (en) * 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
EP1525890A1 (fr) 2003-10-02 2005-04-27 Complex Biosystems GmbH Complexes protéine-protéophore
US7176185B2 (en) * 2003-11-25 2007-02-13 Tsrl, Inc. Short peptide carrier system for cellular delivery of agent
EP1713508A2 (fr) * 2004-01-29 2006-10-25 Biosynexus Incorporated Utilisation de groupes fonctionnels amino-oxy dans la preparation de vaccins
AU2005211775B2 (en) 2004-02-06 2009-10-08 Biomarin Pharmaceutical Inc. Manufacture of highly phosphorylated lysosomal enzymes and uses thereof
PL1740204T3 (pl) 2004-04-01 2018-08-31 Chiesi Farmaceutici S.P.A. Lecznicze zastosowanie alfa-mannozydazy
US8017151B2 (en) * 2004-09-07 2011-09-13 Board Of Regents Of The University Of Nebraska By And Behalf Of The University Of Nebraska Medical Center Amphiphilic polymer-protein conjugates and methods of use thereof
EP1877099B1 (fr) 2005-04-06 2012-09-19 Genzyme Corporation Conjugués thérapeutiques comprenant une enzyme lysosomale, l'acide polysialique et un agent de ciblage
DK2457920T3 (en) 2007-01-18 2018-01-22 Genzyme Corp Oligosaccharides comprising an amino oxy group and conjugates thereof
WO2008089339A2 (fr) 2007-01-18 2008-07-24 Genzyme Corporation Conjugués d'oligosaccharides utilisés pour le ciblage cellulaire
US8835614B2 (en) * 2008-12-16 2014-09-16 Genzyme Corporation Oligosaccharide-protein conjugates

Also Published As

Publication number Publication date
EP2121713B1 (fr) 2013-06-12
EP2457920A1 (fr) 2012-05-30
PL2457919T3 (pl) 2019-12-31
CA2675968C (fr) 2019-05-21
IL199925A (en) 2017-09-28
JP2010516257A (ja) 2010-05-20
WO2008089403A2 (fr) 2008-07-24
LT2457920T (lt) 2018-02-12
DK2457920T3 (en) 2018-01-22
PL2121713T3 (pl) 2013-11-29
US8759501B2 (en) 2014-06-24
WO2008089403A3 (fr) 2008-11-13
JP6039625B2 (ja) 2016-12-07
EP3597655A1 (fr) 2020-01-22
SI2457919T1 (sl) 2019-10-30
JP2018109194A (ja) 2018-07-12
EP3597655B1 (fr) 2023-08-02
JP2020185011A (ja) 2020-11-19
US20200010825A1 (en) 2020-01-09
NO2457920T3 (fr) 2018-03-24
EP2121713A2 (fr) 2009-11-25
HRP20130744T1 (hr) 2013-10-11
DK2457919T3 (da) 2019-09-16
EP4293112A3 (fr) 2024-03-13
IL243117B2 (en) 2023-03-01
ES2656314T3 (es) 2018-02-26
CY1119954T1 (el) 2018-12-12
IL243117A (fr) 2016-01-31
US20170014520A1 (en) 2017-01-19
PT2121713E (pt) 2013-06-25
CN101631794A (zh) 2010-01-20
US20100047225A1 (en) 2010-02-25
US20220204963A1 (en) 2022-06-30
CA2675968A1 (fr) 2008-07-24
US10907142B2 (en) 2021-02-02
PT2457920T (pt) 2018-01-23
NL301210I1 (nl) 2022-12-21
EP4293112A2 (fr) 2023-12-20
HRP20180076T1 (hr) 2018-02-23
HRP20191562T1 (hr) 2019-11-29
IL199925A0 (en) 2010-04-15
FR22C1061I2 (fr) 2023-11-17
HUE045046T2 (hu) 2019-12-30
IL222792A0 (en) 2012-12-31
PT2457919T (pt) 2019-09-20
LT2457919T (lt) 2019-09-25
CN102978185B (zh) 2015-02-11
US20150050262A1 (en) 2015-02-19
JP6309592B2 (ja) 2018-04-11
CN101631794B (zh) 2013-01-02
CY1122452T1 (el) 2021-01-27
JP5999867B2 (ja) 2016-09-28
ES2417146T3 (es) 2013-08-06
JP2017052962A (ja) 2017-03-16
ES2744574T3 (es) 2020-02-25
HUS2200055I1 (hu) 2023-01-28
NO2022056I1 (no) 2022-12-09
DK2121713T3 (da) 2013-06-24
JP2015078360A (ja) 2015-04-23
EP2457919B1 (fr) 2019-06-05
EP2457920B1 (fr) 2017-10-25
PL2457920T3 (pl) 2018-03-30
IL243117B (en) 2022-11-01
US9469850B2 (en) 2016-10-18
JP2022137232A (ja) 2022-09-21
SI2457920T1 (en) 2018-02-28
NL301210I2 (nl) 2023-02-02
EP2457919A1 (fr) 2012-05-30
CN102978185A (zh) 2013-03-20
HUE036140T2 (hu) 2018-06-28

Similar Documents

Publication Publication Date Title
FR22C1061I2 (fr) Oligosaccharides comprenant un groupe aminooxy et des conjugues de celui-ci
BRPI0923473A2 (pt) dispositivo de cigarro simulado, e, sistema
DK3207941T6 (da) Fremgangsmåder og sammensætninger baseret på diphtheritoksin-interleukin-3-konjugater
ZA200802225B (en) Interleukin-1 conjugates and uses thereof
ATE447991T1 (de) Arzneimittelabgabevorrichtung
FR2944571B1 (fr) Ensemble de support antichoc et detecteur comprenant celui-ci
DE602007011305D1 (de) Kaffee- und teedosiersystem
TWI369853B (en) Amplifier and class ab amplifier
TWI349428B (en) Class ab amplifier
GB0515122D0 (en) Intolerance testing device and system
DE112008001073A5 (de) Begasungsvorrichtung und -system
FR2909105B1 (fr) Armoire de sechage.
ITMI20080183A1 (it) Dispositivo amplificatore e sistema impiegante il dispositivo
GB0701081D0 (en) Intolerance testing device and system
SI2121713T1 (sl) Oligosaharidi, ki obsegajo aminooksi skupino, in njihovi konjugati
FR2916702B1 (fr) Console nomade et escamotable.
BRPI0912444A2 (pt) "arranjo de fixação, parte da parede e unidade de conexão"
NL1034526A1 (nl) Emoticoninrichting.
ES1061833Y (es) Aparato de pedaleo estatico transformable en butaca.
ITMO20050146A1 (it) Dispositivo amplificatore.
ES1059871Y (es) Dispositivo alineador de ejes recogedores de cortinas y elementos similares.
NL1034157A1 (nl) Sterilisatie-inrichting.
CL2008000400S1 (es) Aparato desodorizador.
CL2008000476S1 (es) Aparato desodorizador.
CL2007002339S1 (es) Aparato desodorizador.